Journal of Diabetes (JDB) is an open access diabetes and metabolism journal devoted to diabetes research, therapeutics, and education. The journal aims to involve researchers and practitioners in a dialogue between East and West via all aspects of epidemiology, etiology, pathogenesis, management, complications and prevention of diabetes, including the molecular, biochemical, and physiological aspects of diabetes. JDB is an official journal of the Chinese Society of Endocrinology endorsed by the Chinese Endocrinologist Association.

Announcement

Journal of Diabetes has changed to a fully open access journal since 2022. Work published benefits from greater visibility, higher downloads, and more citations.

All submissions received will be subject to an Article Publication Charge (APC) if accepted and published, unless a waiver is applied. Journal of Diabetes does not charge submissions fees. For more information on the fees, please click here.

Skip slideshow

Articles

REVIEW ARTICLE
Open access

Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetes

  •  25 April 2024

Graphical Abstract

Description unavailable

Highlights

  • The crucial role of glucokinase (GK) in the homeostatic system maintains the balance of glucose levels.
  • GK also influences the secretion of essential endocrine hormones like glucagon and glucagon-like peptide-1 (GLP-1).
  • Studies in a broader population of patients with diabetes and prediabetes will provide greater clinical evidence for the long-term effects of GK activation.

ORIGINAL ARTICLE
Open access

Gamma‐glutamyl transferase and the risk of all‐cause and disease‐specific mortality in patients with diabetes: A nationwide cohort study

  •  25 April 2024

Graphical Abstract

Description unavailable

Highlights

  • This Korean nationwide population-based cohort study analyzed the overall and disease-specific mortality according to serum gamma-glutamyl transferase (GGT) levels in patients with type 2 diabetes.
  • GGT levels were positively associated with various causes of mortality, including cardiovascular disease, cancer, liver disease, respiratory disease, and infectious disease.
  • Notably, the increased risk of all-cause mortality was more prominent in the subgroups of the young, underweight, and those with complications of type 2 diabetes.
  • Serum GGT levels may be useful for the risk assessment of all-cause and disease-specific mortality among patients with type 2 diabetes.

ORIGINAL ARTICLE
Open access

Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model—A multiregional case study

  •  25 April 2024

Graphical Abstract

Description unavailable

Highlights

  • Countries moving from low to middle income are most at risk from the type 2 diabetes (T2D) “epidemic” and may find implementing preventative measures challenging; yet prevention has largely been evaluated in developed countries.
  • This study explored costs and benefits of various prediabetes management approaches in Poland, Saudi Arabia, and Vietnam, with the aim of facilitating resource use and planning decisions.
  • Pharmacological and lifestyle prediabetes interventions offer promise for reducing T2D incidence. In the context of adherence concerns and funding/reimbursement challenges for lifestyle interventions, metformin alone may be an effective, cost-saving strategy.

REVIEW ARTICLE
Open access

Acellular fish skin grafts in the treatment of diabetic wounds: Advantages and clinical translation

  •  25 April 2024

Graphical Abstract

Description unavailable

Highlights

  • Concisely included the latest research on the role of acellular fish skin grafts (AFSGs) in treating diabetic wounds, providing readers with a basic framework,
  • This review outlined the therapeutic advantages and prospects of AFSGs,
  • This work emphasized the role of cost-effectiveness in the treatment of diabetic wound dressings.
  • We summarized the shortcomings and corrective measures of current AFSGs clinical trials.
  • We explored the resistance that may be encountered by AFSGs in various stages of clinical studies.

ORIGINAL ARTICLE
Open access

The metabolic effects of habitual leg shaking: A randomized crossover trial

  •  25 April 2024

Graphical Abstract

Description unavailable

Highlights

  • Previous research has established the detrimental effects of sedentary behavior on obesity and chronic diseases. Efforts to mitigate heightened sedentary behavior through measures such as promoting elevated physical activity or incorporating extended standing and exercise during sedentary intervals have faced challenges in implementation.
  • Our study confirmed that habitual leg shaking effectively increased energy expenditure by approximately 16.3%, elevated the metabolic equivalent to a nonhealthy level, enhanced carbohydrate oxidation, improved blood oxygen saturation and minute ventilation, while avoiding additional cardiovascular burden.
  • Leg shaking offers a simple and feasible approach to enhance physical activity without disrupting daily routines.

ORIGINAL ARTICLE
Open access

Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes

  •  25 April 2024

Graphical Abstract

Description unavailable

Highlights

  • This study is the first to evaluate the effects of multiple daily injection and continuous subcutaneous insulin infusion therapy among Chinese pregnant women with type 1 diabetes.
  • We found that pregnant women with type 1 diabetes on continuous subcutaneous insulin infusion therapy had better glycemic control in the third trimester than those on multiple daily injection therapy.
  • Continuous subcutaneous insulin infusion users had a significant decline in glycated hemoglobin (HbA1c) level from preconception to the third trimester.
  • There was a nonsignificant lower HbA1c level for women treated with long-acting insulin, compared with neutral protamine Hagedorn.

ORIGINAL ARTICLE
Open access

Epidemiology of type 1 diabetes mellitus in children and adolescents: A 50‐year, single‐center experience

  •  25 April 2024

Graphical Abstract

Description unavailable

Highlights

  • This study provides important data from a single quarternary reference center where cases with type 1 diabetes mellitus (T1DM) come from a wide range of geographical distribution over 50 years and may well reflect secular trends in T1DM in Turkey.
  • The mean age at diagnosis was 9.5 ± 4.0 years from 1969 to 1990, and it significantly decreased to 7.1 ± 3.6 years over the subsequent 50 years. Similarly, age at diagnosis peaked at 12–14 years between 1969 and 1990, then fell to 10–11.9 years between 1990 and 1999, and to 4–5.9 years between 2000–2009 and 2010–2019.
  • Although the percentage of patients diagnosed <6 years of age is gradually increasing, the percentage diagnosed between ages of 6 and 11.9 years is decreasing, and the percentage diagnosed ≥12 years remained stable.
  • Approximately half of the patients had ketoacidosis at the time of diagnosis and the frequency of presentation with DKA did not decrease, but the severity decreased slightly.
  • Although the frequency of patients with mild DKA increased over time, frequency of patients with moderate DKA decreased; however, no significant difference was observed among patients with severe ketoacidosis.

ORIGINAL ARTICLE
Open access

Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus

  •  25 April 2024

Graphical Abstract

Description unavailable

Highlights

  • A nonalcoholic fatty liver disease (NAFLD) prevalence of 59.36% and a liver cirrhosis prevalence of 1.43% was found among type 2 diabetes mellitus (T2DM) patients.
  • Significant risk factors for NAFLD were identified, including age, gender, marital status, and obesity, with obesity showing a particularly strong positive association.
  • The glycated hemoglobin (HbA1c)-NAFLD relationship displayed a linear pattern that mimicked an inverted L-shaped pattern. A significant positive association existed between HbA1c levels and NAFLD for HbA1c <8.00%, but this was not observed for HbA1c >8.00%.

ORIGINAL ARTICLE
Open access

The association between sodium glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population‐based cohort study

  •  10 April 2024

Graphical Abstract

Description unavailable

Highlights

  • What are the new findings?

This was the first Australian study using real-world data to show SGLT-2is reduce ARF and CKD compared to DPP-4is in people with type 2 diabetes. The rates of hospital admissions for ARF and CKD in people with type 2 diabetes were 22% and 17% lower, respectively, among SGLT-2i initiators compared to DPP-4i initiators.

  • How might this have an impact on clinical practice in the foreseeable future?
Our study suggests that benefits of SGLT-2is apparent in clinical trials, in preventing acute and chronic renal events in people with type 2 diabetes, are reflected in real-world clinical practice.

More articles
More articles
More articles

Recent issues

Latest news